Try
Qiagen N.V. Common Shares
QGENUnited States
85 filed reports · 837 financial concepts · 32 earnings calls · 6 media appearances
Filed reports
85 reports · Jun 2007 to Jun 2026Each report counts once it has at least one extracted financial fact. Also extracted from these reports: 406 guidance figures, 8 interim figures.
| Report type | Reports | Facts | Periods |
|---|---|---|---|
| Interim · 6-KSEC EDGAR | 69 | 516 | Jun 2007 to Jun 2026 |
| Annual · 20-FSEC EDGAR | 16 | 9,917 | Dec 2010 to Dec 2025 |
Documents
| Period | Type | Period end | Published | Facts | Source |
|---|---|---|---|---|---|
| FY2026 Q2 | 6-K | Jun 30, 2026 | Aug 7, 2026 | 10 | Open |
| FY2026 Q2 | 6-K | Jun 30, 2026 | Aug 7, 2026 | 26 | Open |
| FY2026 Q1 | 6-K | Mar 31, 2026 | May 8, 2026 | 20 | Open |
| FY2026 Q1 | 6-K | Mar 31, 2026 | May 8, 2026 | 2 | Open |
| FY2025 | 20-F | Dec 31, 2025 | Mar 20, 2026 | 1,102 | Open |
| FY2025 Q3 | 6-K | Sep 30, 2025 | Nov 6, 2025 | 26 | Open |
| FY2025 Q3 | 6-K | Sep 30, 2025 | Nov 6, 2025 | 10 | Open |
| FY2025 Q2 | 6-K | Jun 30, 2025 | Aug 21, 2025 | 13 | Open |
| FY2024 | 20-F | Dec 31, 2024 | Mar 31, 2025 | 544 | Open |
| FY2024 Q1 | 6-K | Mar 31, 2024 | May 1, 2024 | 9 | Open |
| FY2023 | 20-F | Dec 31, 2023 | Mar 11, 2024 | 514 | Open |
| FY2022 | 20-F | Dec 31, 2022 | Mar 13, 2023 | 581 | Open |
Financial data
837 concepts · 10,433 factsEach concept is one reported line item or metric. The count is how many values of it are held, across the periods shown.
Financial812 concepts · 9,786 facts · Dec 2008 to Jun 2026
- Depreciation and amortization66 · Dec 2009 to Dec 2025
- Interest rate contracts64 · Dec 2018 to Dec 2025
- Line of credit facility maximum borrowing capacity60 · Dec 2011 to Dec 2025
- Share-based compensation58 · Dec 2009 to Dec 2025
- Interest46 · Dec 2012 to Dec 2024
- Convertible debt42 · Dec 2013 to Dec 2024
- Cash and cash equivalents at carrying value36 · Dec 2008 to Dec 2025
- Goodwill (US GAAP)36 · Dec 2008 to Dec 2025
- Product warranty accrual36 · Dec 2008 to Dec 2025
- Unrecognized tax benefits36 · Dec 2008 to Dec 2025
- Accounts payable current34 · Dec 2009 to Dec 2025
- Accounts receivable net current34 · Dec 2009 to Dec 2025
- Accrued contingent consideration and milestone payments34 · Dec 2009 to Dec 2025
- Accrued interest on long-term debt34 · Dec 2009 to Dec 2025
- Accrued liabilities current34 · Dec 2009 to Dec 2025
- Accrued royalties current34 · Dec 2009 to Dec 2025
- Accumulated depreciation depletion and amortization property plant and equipment34 · Dec 2009 to Dec 2025
- Accumulated other comprehensive income loss net of tax34 · Dec 2009 to Dec 2025
- Additional paid in capital34 · Dec 2009 to Dec 2025
- Allowance for doubtful accounts receivable current34 · Dec 2009 to Dec 2025
- Assets34 · Dec 2009 to Dec 2025
- Assets current34 · Dec 2009 to Dec 2025
- Assets noncurrent34 · Dec 2009 to Dec 2025
- Common stock par or stated value per share34 · Dec 2009 to Dec 2025
Guidance10 concepts · 400 facts · Jun 2007 to Jul 2021
- EPS (Diluted) Guidance183 · Jun 2007 to Jul 2021
- Revenue Growth Guidance176 · Aug 2009 to Jul 2021
- Revenue Guidance13 · Jun 2007 to Jul 2021
- EPS (Diluted) Growth Guidance8 · Jun 2008 to Jul 2020
- Effective Tax Rate Guidance6 · Dec 2017 to Feb 2018
- EPS (Diluted) Guidance (Adjusted (non-GAAP))6 · Feb 2009 to Sep 2009
- EPS (Diluted) Guidance (foreign currency exchange rates as of January 31, 2009; Adjusted (non-GAAP))2 · Feb 2009
- Revenue Growth Guidance (Constant currency)2 · Feb 2009
- Revenue Guidance (Constant currency)2 · Feb 2009
- Revenue Guidance (foreign currency exchange rates as of January 31, 2009)2 · Feb 2009
Geography3 concepts · 129 facts · Dec 2008 to Dec 2025
- Revenue126 · Dec 2008 to Dec 2025
- Income tax expense benefit2 · Dec 2013 to Dec 2014
- Restructuring, acquisition, integration and other, net1 · Dec 2022
Product1 concepts · 74 facts · Dec 2008 to Dec 2025
- Revenue74 · Dec 2008 to Dec 2025
Segment11 concepts · 44 facts · Dec 2022 to Dec 2025
- Cost of goods and services sold (US GAAP)4 · Dec 2022 to Dec 2025
- Gross profit (US GAAP)4 · Dec 2022 to Dec 2025
- Income loss from continuing operations before income taxes extraordinary items noncontrolling interest4 · Dec 2022 to Dec 2025
- Income tax expense benefit4 · Dec 2022 to Dec 2025
- Net income loss4 · Dec 2022 to Dec 2025
- Nonoperating income expense4 · Dec 2022 to Dec 2025
- Operating expenses (US GAAP)4 · Dec 2022 to Dec 2025
- Operating income loss4 · Dec 2022 to Dec 2025
- Other cost and expense operating4 · Dec 2022 to Dec 2025
- Reportable Segment4 · Dec 2022 to Dec 2025
- Revenue4 · Dec 2022 to Dec 2025
Segments
247 factsFigures broken down by business line, region, product or another axis the company reports on.
Statement geographicalus-gaap:StatementGeographicalAxis9 members · 68 facts
- NL11 · Dec 2009 to Dec 2017
- Asia Pacific And Rest Of World10 · Dec 2008 to Dec 2017
- Other Americas10 · Dec 2008 to Dec 2017
- Total Americas10 · Dec 2008 to Dec 2017
- EMEA6 · Dec 2012 to Dec 2017
- Europe6 · Dec 2008 to Dec 2013
- United States6 · Dec 2008 to Dec 2013
- US6 · Dec 2012 to Dec 2017
- Netherlands3 · Dec 2008 to Dec 2010
Statement geographicalsrt:StatementGeographicalAxis7 members · 61 facts
- Asia Pacific And Rest Of World10 · Dec 2016 to Dec 2025
- EMEA10 · Dec 2016 to Dec 2025
- NL10 · Dec 2016 to Dec 2025
- Other Americas10 · Dec 2016 to Dec 2025
- Total Americas10 · Dec 2016 to Dec 2025
- US10 · Dec 2016 to Dec 2025
- RU1 · Dec 2022
Product or servicesrt:ProductOrServiceAxis7 members · 54 facts
- Diagnostic Solutions8 · Dec 2018 to Dec 2025
- Genomics NGS8 · Dec 2018 to Dec 2025
- PCR Nucleic Acid Amplification8 · Dec 2018 to Dec 2025
- Product And Service Other8 · Dec 2018 to Dec 2025
- Sample Technologies8 · Dec 2018 to Dec 2025
- Consumablesand Related7 · Dec 2016 to Dec 2025
- Instruments7 · Dec 2016 to Dec 2025
Statement business segments1 member · 44 facts
- Reportable44 · Dec 2022 to Dec 2025
Product or serviceus-gaap:ProductOrServiceAxis2 members · 20 facts
- Consumables And Related Revenues10 · Dec 2008 to Dec 2017
- Instrumentation10 · Dec 2008 to Dec 2017
Text from filings
Management commentary and risk factors, extracted from SEC filings only.
- Management discussion (MD&A) commentary6 claims from 1 reports · Dec 2024
- Risk factors34 risks from 1 annual reports · 2025
Earnings calls
32 calls · May 2018 to Aug 2026Transcripts with management claims and analyst questions, one per fiscal period.
- FY2026 Q2Aug 6, 2026
- FY2026 Q1Apr 28, 2026
- FY2025 Q4Feb 5, 2026
- FY2025 Q3Nov 5, 2025
- FY2025 Q2Aug 6, 2025
- FY2025 Q1May 8, 2025
- FY2024 Q4Feb 6, 2025
- FY2024 Q3Nov 7, 2024
- FY2024 Q2Aug 1, 2024
- FY2024 Q1Apr 30, 2024
- FY2023 Q4Feb 7, 2024
- FY2023 Q3Oct 31, 2023
- FY2023 Q2Aug 9, 2023
- FY2023 Q1May 4, 2023
- FY2022 Q4Feb 8, 2023
- FY2022 Q3Nov 8, 2022
Executive media
6 appearancesPodcasts, interviews and conference appearances by the company's executives, with their claims.
- Other appearances3 · Nov 2023 to Aug 2024
- TV interviews2 · Nov 2020 to Jun 2022
- Conference talks1 · Aug 2026
Reports are counted as filed reports with at least one served fact. Counts are read from the database (last read Oct 16, 2026) and refreshed every few hours.